Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Continuation of the Cardiovascular Repository for-Type 1…

U.S. National Institutes of Health·United States of America

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Closes 3/10/2027$400k – $6MGrants Notice
Get bids like this by emailBid source

Description

The National Institutes of Health (NIH) is seeking applications for the Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium. The purpose of this funding opportunity is to promote collaborative and interdisciplinary research aimed at enhancing the understanding of the development of cardiovascular disease in individuals with type 1 diabetes. The key aspects of this opportunity include: • The creation of a consortium to conduct hypothesis-driven research on the pathogenesis of cardiac disease in type 1 diabetes using multi-omics and molecular approaches • The utilization of the U01 mechanism activity code for the investigative teams • The encouragement of collaborative investigations combining expertise in type 2 diabetes, atherosclerosis, inflammation, and cutting-edge omics techniques • The requirement for a Data Management and Sharing Plan (DMS Plan) to address the elements in the structured format • The availability of funding for up to 8 awards, with an estimated total funding of $6,000,000 and an award ceiling of $500,000

Attached files

Contact

Chandima Nishadi De Abrew Rajapakse

[email protected], [email protected], [email protected], [email protected]

(240) 429-5197

Key dates

Opened
9/18/2025
Closes
3/10/2027
Projected award
3/1/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-DK-27-108

Budget estimate

$400,000 – $6,000,000

Based on the document, the estimated funding for this opportunity is $6,000,000, with an award ceiling of $500,000. The budget amount will depend on the number of awards made and the specific projects proposed. The NIH may adjust the funding levels based on the number of meritorious applications received. Factors that may influence the likely payment range include the scope of the proposed research, the number of personnel involved, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 88%

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

Closes 3/9/2027Opened 8/4/2026

U.S. National Institutes of Health·United States of America

86% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

86% match

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Closes 2/9/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

84% match

The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

Closes 10/12/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

82% match

Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional)

Closes 2/4/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

82% match

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Closes 3/6/2027Opened 6/17/2025

U.S. National Institutes of Health·United States of America

82% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

82% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

82% match

Diabetes Research Centers (P30 Clinical Trial Optional)

Closes 1/27/2027Opened 5/27/2025

U.S. National Institutes of Health·United States of America

81% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

81% match

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

Closes 5/31/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

81% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

81% match

Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)

Closes 11/17/2026Opened 9/18/2025

U.S. National Institutes of Health·United States of America

81% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

81% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

81% match

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

Closes 4/15/2027Opened 10/29/2024

U.S. National Institutes of Health·United States of America

81% match

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Closes 7/20/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

80% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

80% match

Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)

Closes 11/5/2029Opened 9/29/2025

U.S. National Institutes of Health·United States of America

80% match

Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)

Closes 1/25/2027Opened 2/19/2026

U.S. National Institutes of Health·United States of America

80% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

80% match

NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional)

Closes 1/27/2027Opened 7/1/2026

U.S. National Institutes of Health·United States of America

80% match

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. National Institutes of Health·United States of America

79% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. National Institutes of Health·United States of America

79% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025